NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/09/2023
Back to search
Official data from USPTO
HANHUI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
04/09/2023
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
01/30/2021
Registration date
06/28/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/28/2022
Last transaction
06/28/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
CN
Examiner
MUMM, WHITLEY
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Hanhui Pharmaceuticals Co., Ltd.
Representatives
Christine P. James Kilpatrick Townsend & Stockton LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in chemotherapyradiotherapyendocrine therapyanesthesia; Pharmaceutical preparations for supplementing vitamins and nutritiondietary and nutritional supplements; Pharmaceutical preparations for anti-infection and antiviral purposes; Pharmaceutical preparations for improving lactation functions; Pharmaceutical preparations for treating hematological diseasesanemialeucocyte disordersblood clots; Pharmaceutical preparations for treating cardiovascular and cerebrovascular diseasesblood lipid disorderblood pressure disorderarrhythmiacardiac insufficiencyangina pectorismyocardial infarction; Pharmaceutical preparations for treating respiratory system diseasesphlegmcoughasthma; Pharmaceutical preparations for treating digestive system diseases and disorderspeptic ulcerdiarrhea; Pharmaceutical preparations for treating central nervous diseases and disordersfever and paingoutepilepsyParkinsonian syndromepsychotic disordersdepressionanxietymania; Pharmaceutical preparations for treating geriatric diseaseshyperosteogenyprostatic hyperplasiasenile cataract; Pharmaceutical preparations for treating genitourinary system diseasesendocrine and metabolic system diseases and disordersallergiesimmune system diseases and disordersliver and gall diseasesAlzheimer's diseasesskin diseases and disordersobstetric and gynecological diseases and disordersdiseases with eyeearnosemouthoral cavitythroat; Chemical preparations for pharmaceutical and medical purposesantineoplastic drugsantibioticsanti-infectivesvitamins and nutritional supplementsanestheticsthose for treating hematological system diseasescardiovascular and cerebrovascular diseasesendocrine and metabolic diseases and disordersrespiratory system diseasesdigestive system diseases and disorderscentral nervous system diseases and disordersdermatological diseasesobstetric and gynecological diseases and disordersophthalmology and otorhinolaryngology diseasesgeriatric diseases; Analgesics; Medicines for humansantineoplastic drugsanti-infectivesantibioticsanestheticsvitamin and nutritional supplementsmedicines for the treatment of allergycardiovascular and cerebrovascular diseasesdermatological diseasesgeriatric diseasesdiseases with hematological systemgenitourinary systemendocrine and metabolic systemimmune systemrespiratory systemdigestive systemcentral nervous systemobstetrics and gynecology systemeyeearmouththroat; Sedatives; Tranquillizers; Biological preparations for medical purposesvaccinesantineoplastic preparationsantitoxinantisera; Antibiotics; Injectable pharmaceuticalsantineoplastic drugsanti-infectivesantibioticsanestheticsvitamin and nutritional supplementsthose for the treatment of allergycardiovascular and cerebrovascular diseasesdermatological diseasesgeriatric diseasesophthalmology and otorhinolaryngology diseasesdiseases with hematological systemgenitourinary systemendocrine and metabolic systemimmune systemrespiratory systemdigestive systemcentral nervous systemobstetrics and gynecology system; Tabletsantineoplastic drugsanti-infectivesantibioticsanestheticsvitamin and nutritional supplementstablets for the treatment of allergycardiovascular and cerebrovascular diseasesdermatological diseasesgeriatric diseasesophthalmology and otorhinolaryngology diseasesdiseases with hematological systemgenitourinary systemendocrine and metabolic systemimmune systemrespiratory systemdigestive systemcentral nervous systemobstetrics and gynecology system; Bulk medicinesantineoplastic drugsanti-infectivesantibioticsanestheticsvitamin and nutritional supplementsmedicines for the treatment of allergycardiovascular and cerebrovascular diseasesdermatological diseasesgeriatric diseasesophthalmology and otorhinolaryngology diseasesdiseases with hematological systemgenitourinary systemendocrine and metabolic systemimmune systemrespiratory systemdigestive systemcentral nervous systemobstetrics and gynecology system; Biochemical medicinesantineoplastic drugsanti-infectivesantibioticsmedicines for the treatment of allergycardiovascular and cerebrovascular diseasesdiseases with hematological systemgenitourinary systemendocrine and metabolic systemimmune systemrespiratory systemdigestive systemcentral nervous system; Blood for medical purposes; Herbal tinctures for medical purposes; Diagnostic preparations for medical purposes; Chemical reagents for medical or veterinary purposes; Radium for medical purposes; Radioactive substances for medical purposes; Isotopes for medical purposes; Radioactive medicines for medical imaging and the treatment of tumor and thyroid diseases; Oxygen for medical purposes; Chemical conductors for electrocardiograph electrodes; Semen for artificial insemination; Disinfectants for hygiene purposes; Disinfectants; Solutions for contact lenses; Contact lens cleaning preparations; Media for bacteriological cultures; Bouillons for bacteriological cultures; Bacteriological culture mediums; Nutritive substances for microorganisms for medical purposes; Cultures of microorganisms for medical and veterinary use; Disinfectant wipes; Wadding for medical purposes; Food for babies
Publications
History of USPTO decisions and trademark events.
34 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/01/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/06/2022
FIMP
FINAL DISPOSITION PROCESSED
10/06/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/28/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/21/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/28/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2022
PUBO
PUBLISHED FOR OPPOSITION
04/12/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/23/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/08/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/08/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/08/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/08/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/28/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/28/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/28/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/28/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/28/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/28/2022
RFNT
REFUSAL PROCESSED BY IB
09/20/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/28/2021
RFRR
REFUSAL PROCESSED BY MPU
08/28/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/24/2021
CNRT
NON-FINAL ACTION WRITTEN
08/23/2021
DOCK
ASSIGNED TO EXAMINER
08/19/2021
MAFR
APPLICATION FILING RECEIPT MAILED
03/30/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/26/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/25/2021
Continuous trademark protection
Get notified about every new filing that threatens HANHUI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.